Diagnostic Imaging Market Report by Product, Application, End User, Countries and Company Analysis 2026-2034

Diagnostic Imaging Market Size and Forecast

Diagnostic Imaging Market is projected to grow from US$ 41.32 billion in 2025 to US$ 68.81 billion by 2034, registering a CAGR of 5.83% during 2026–2034. The market is expected to witness steady expansion, driven by the growing need for early and accurate disease detection, increasing prevalence of chronic and age-related disorders, and rapid integration of artificial intelligence into medical imaging workflows. Furthermore, improving access to diagnostic healthcare services, expanding training and healthcare infrastructure, and the introduction of technologically advanced X-ray, computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound systems are supporting wider adoption worldwide.

What is Diagnostic Imaging and its Uses & Popularity Worldwide

Diagnostic imaging refers to a group of medical technologies used to create detailed images of internal organs, tissues, bones, blood vessels, and other structures to identify and monitor diseases and injuries. Major modalities include X-ray, computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, mammography, and nuclear imaging. These technologies are widely used for cancer detection, cardiovascular assessment, neurological diagnosis, orthopedic evaluation, pregnancy monitoring, trauma assessment, and treatment planning. Diagnostic imaging also supports screening, disease monitoring, surgical guidance, and evaluation of treatment outcomes.

The World Health Organization (WHO) identifies imaging tests such as chest radiography, mammography, and pelvic ultrasound as important components of diagnostic services. Diagnostic results influence approximately 70% of healthcare decisions, while diagnostic services receive only about 3–5% of healthcare budgets, highlighting their importance and potential for further investment. Worldwide popularity is increasing as healthcare systems emphasize earlier diagnosis, preventive care, minimally invasive procedures, and personalized treatment. Growing chronic disease and cancer burdens are further strengthening demand for accessible and technologically advanced imaging systems.

Top Countries with CT scanners, MRI units and PET scanners, 2023

• Japan: 184
• Australia: 94
• Greece: 92
• Korea: 87
• United States: 86
• Italy: 79
• Germany: 74
• Switzerland: 72
• Iceland: 70

Growth Drivers of the Diagnostic Imaging Market

Rising Burden of Chronic Diseases and Cancer

The increasing prevalence of chronic diseases is a major factor supporting demand for diagnostic imaging worldwide. Conditions such as cancer, cardiovascular disease, diabetes, neurological disorders, and respiratory diseases frequently require imaging for diagnosis, staging, treatment planning, and follow-up. WHO reported that noncommunicable diseases accounted for at least 43 million deaths globally in 2021, with cardiovascular diseases, cancers, chronic respiratory diseases, and diabetes representing the major disease groups. The global cancer burden is particularly significant, with approximately 20 million new cancer cases and 9.7 million cancer deaths recorded in 2022. IARC also projects that annual new cancer cases could reach 35 million by 2050, representing a 77% increase from 2022. Diagnostic imaging technologies such as CT, MRI, PET, mammography, and ultrasound are increasingly incorporated into screening and clinical pathways. As disease prevalence increases and healthcare providers emphasize earlier detection, demand for accurate and repeatable imaging examinations is expected to expand across hospitals, diagnostic centers, and specialized clinics.

Rapid Adoption of Artificial Intelligence in Medical Imaging

The integration of artificial intelligence (AI), machine learning, and advanced image-processing technologies is transforming diagnostic imaging by improving workflow efficiency, image reconstruction, detection, and clinical decision support. AI can assist radiologists in identifying abnormalities, prioritizing urgent examinations, segmenting lesions, improving image quality, and automating repetitive tasks. The U.S. Food and Drug Administration’s database of AI-enabled medical devices shows numerous recent radiology products covering CT, MRI, ultrasound, X-ray, and other imaging applications. In 2024 alone, the FDA database included clearances for products such as Siemens AI-Rad Companion, Canon’s CT and MRI technologies, Philips diagnostic ultrasound systems, GE Healthcare imaging technologies, and multiple AI-based radiology software solutions. The American College of Radiology also reported continued additions of FDA-cleared imaging AI products during 2024, including applications for CT and ultrasound. Growing adoption of AI-enabled reconstruction, automated detection, triage, and workflow optimization is therefore creating opportunities for imaging equipment manufacturers and healthcare providers.

Increasing Demand for Early and Accurate Diagnosis

Growing emphasis on early disease detection and preventive healthcare is encouraging hospitals and diagnostic facilities to expand imaging capabilities. Imaging enables physicians to identify abnormalities before symptoms become severe, characterize disease progression, guide interventions, and monitor therapeutic responses. This is particularly important for cancer, cardiovascular conditions, neurological disorders, and traumatic injuries. WHO states that diagnostic services are essential for prevention, screening, diagnosis, case management, monitoring, and treatment of communicable and noncommunicable diseases. The need for diagnostic capacity is also evident from disparities in imaging infrastructure between countries. The IAEA’s global IMAGINE database covers medical imaging and nuclear medicine equipment and human resources across more than 170 countries and territories, illustrating the scale of worldwide imaging infrastructure requirements. Improvements in digital radiography, portable ultrasound, faster CT scanners, high-field MRI, and automated image analysis are making imaging services increasingly useful across emergency departments, outpatient centers, specialty hospitals, and community healthcare settings. Consequently, investments aimed at improving diagnostic accessibility and accuracy are supporting market expansion.

Challenges of the Diagnostic Imaging Market

High Equipment Costs and Unequal Access

High acquisition, installation, maintenance, and operating costs remain important barriers to the wider adoption of advanced diagnostic imaging technologies, particularly in low- and middle-income countries. MRI and CT systems require substantial capital investment, specialized infrastructure, trained personnel, regular maintenance, and reliable electricity supplies. WHO notes that some imaging technologies require important infrastructure and specialized healthcare workers, with CT scanners being a prominent example. The disparity in equipment availability can significantly affect access to timely diagnosis. The IAEA’s IMAGINE database highlights differences in imaging resources across income groups and reports that one CT scanner served substantially different population sizes depending on a country’s income level. In addition to purchasing costs, healthcare providers must account for software upgrades, replacement parts, service contracts, facility modifications, and staff training. These financial and infrastructure requirements can slow adoption in resource-constrained markets and contribute to geographic differences in access to advanced MRI, CT, mammography, and nuclear imaging services.

Shortage of Skilled Professionals and Regulatory Complexity

The expansion of diagnostic imaging is also challenged by shortages of trained radiologists, radiographers, technicians, biomedical engineers, and other specialized healthcare personnel. Advanced imaging systems require appropriately trained professionals to operate equipment, acquire high-quality images, interpret results, maintain systems, and ensure patient safety. WHO has emphasized the importance of training healthcare professionals when imaging resources are limited, particularly in developing countries. At the same time, the increasing incorporation of AI introduces additional requirements related to validation, clinical performance monitoring, data quality, cybersecurity, interoperability, and regulatory oversight. The American College of Radiology highlighted the emerging oversight considerations associated with generative-AI-enabled medical devices, including the need to monitor clinical AI performance over time. Healthcare institutions must therefore balance technological innovation with appropriate validation, regulatory compliance, staff training, and patient-data protection. These requirements can increase implementation complexity and slow the deployment of sophisticated imaging technologies in some healthcare environments.

Diagnostic Imaging Product Launches Worldwide

1. Philips Verida Spectral CT – Global, 2025
   Philips launched Verida at RSNA 2025 as a detector-based spectral CT system powered by AI. The platform integrates AI across the imaging chain to improve image quality, reduce noise and support faster clinical workflows.
2. Siemens Healthineers MAGNETOM Flow MRI – India, 2025
   Siemens Healthineers showcased the 1.5T MAGNETOM Flow MRI at AOCR 2025. The system uses Dry Cool technology and a virtually helium-free design, supporting more sustainable MRI operations.
3. Siemens Healthineers SOMATOM Pro.Pulse CT – India, 2025
   The SOMATOM Pro.Pulse Dual Source CT scanner was introduced as part of Siemens Healthineers’ AOCR 2025 diagnostic imaging portfolio. It was presented alongside MRI, digital X-ray, and ultrasound technologies.
4. Philips CT 5300 – India, 2025
   Philips launched its AI-enabled CT 5300 at AOCR 2025. The system is designed for diagnostic examinations, screening, and interventional procedures while incorporating AI capabilities intended to improve workflow and diagnostic confidence.
5. Samsung R20 Ultrasound System – India, 2025
   Samsung launched the R20 ultrasound system for general imaging in November 2025. It incorporates Crystal Architecture technology, AI-driven automation, and an ergonomic design aimed at improving image quality and workflow efficiency.
6. Samsung–NeuroLogica Mobile CT Portfolio – India, 2025
   Samsung India and its NeuroLogica subsidiary launched a next-generation mobile CT portfolio in India. The systems combine mobility with AI-assisted imaging and are designed to enable bedside imaging while reducing patient transfers.
7. Canon Aquilion ONE INSIGHT Evolution – Global, 2025
   Canon highlighted an evolution of its Aquilion ONE INSIGHT CT platform incorporating proprietary AI technologies. The upgraded system includes CLEAR Motion Cardiac AI dynamic correction alongside PIQE AI high-definition reconstruction to support clearer cardiac imaging.
8. GE HealthCare Photonova Spectra Photon Counting CT – Global, 2025
   GE HealthCare unveiled Photonova Spectra at RSNA 2025. The photon-counting CT concept uses Deep Silicon photon-counting technology and accelerated computing to process substantially larger volumes of imaging data. The company stated that the system was 510(k) pending and not available for sale at the time of the announcement.
9. GE HealthCare SIGNA Sprint with Freelium – Global, 2025
   GE HealthCare introduced SIGNA Sprint with Freelium at RSNA 2025. The 1.5T MRI platform combines a helium-free approach with image-quality technologies and intelligent automation, targeting more sustainable and efficient MRI operations. The company noted that regulatory status applied at the time of announcement.
10. Siemens Healthineers ACUSON Maple Ultrasound – India, 2025
    Siemens Healthineers showcased ACUSON Maple at AOCR 2025 as an AI-powered ultrasound system designed for diverse clinical environments. Its lightweight, portable design and battery capability make it suitable for hospitals, diagnostic centers, and healthcare facilities in underserved areas.

X-Ray Market

The X-ray market remains a fundamental component of diagnostic imaging because X-ray examinations provide rapid and relatively accessible visualization of bones, lungs, and other anatomical structures. X-ray systems are widely used for detecting fractures, chest abnormalities, infections, dental conditions, and traumatic injuries across hospitals, outpatient centers, emergency departments, and specialized clinics. The global scale of radiological imaging underscores its importance: WHO reports that more than 3.6 billion diagnostic radiology examinations are performed worldwide each year, although this figure includes multiple modalities beyond conventional X-ray. Digital radiography is increasingly replacing traditional film-based systems because it enables faster image acquisition, electronic storage, easier image sharing, and integration with hospital information systems. Portable and mobile X-ray systems are also expanding access in intensive-care units, emergency rooms, operating theaters, and remote healthcare settings. AI-assisted image analysis and automated positioning technologies are further improving workflow and supporting clinical interpretation. Meanwhile, radiation-protection technologies remain important as healthcare providers seek to optimize exposure while maintaining diagnostic quality. These developments are sustaining demand for modern X-ray equipment worldwide.

Ultrasound Market

The ultrasound market represents an important segment of diagnostic imaging because it provides real-time visualization without exposing patients to ionizing radiation. Ultrasound is extensively used for obstetric and gynecological examinations, abdominal imaging, cardiovascular assessment, vascular studies, musculoskeletal evaluation, and image-guided procedures. Its portability, comparatively lower equipment cost, and ability to operate at the point of care make it particularly valuable in emergency departments, primary-care facilities, ambulances, and resource-limited settings. WHO and the World Federation for Ultrasound in Medicine and Biology have highlighted ultrasound’s applications across general, pediatric, gynecological, and musculoskeletal examinations. Technological development is broadening its use through compact handheld systems, wireless probes, higher-resolution imaging, elastography, Doppler capabilities, and AI-assisted measurements. Portable ultrasound is especially useful for rapid assessment when conventional imaging infrastructure is unavailable or when moving critically ill patients is undesirable. AI can automate measurements, guide examinations, and support image acquisition, potentially reducing operator variability. As healthcare systems emphasize earlier diagnosis, decentralized care, and point-of-care assessment, the combination of portability, safety, and real-time imaging continues to support worldwide ultrasound adoption.

Orthopedics Market

The orthopedics market has a strong connection with diagnostic imaging because imaging is essential for identifying and monitoring fractures, arthritis, osteoporosis, joint degeneration, sports injuries, and spinal disorders. X-ray remains widely used for initial bone and joint assessment, while CT provides detailed three-dimensional visualization of complex fractures and MRI enables evaluation of cartilage, ligaments, muscles, tendons, and other soft tissues. Ultrasound is also increasingly useful for selected musculoskeletal and image-guided applications. The underlying patient population is substantial. WHO estimates that approximately 1.71 billion people worldwide live with musculoskeletal conditions, while fractures affect about 440 million people globally. Population ageing and growth are contributing to increasing numbers of people living with musculoskeletal conditions and associated functional limitations. Advanced imaging technologies are therefore becoming increasingly important in orthopedic diagnosis, surgical planning, rehabilitation, and treatment monitoring. Three-dimensional reconstruction, digital radiography, AI-assisted image interpretation, and image-guided interventions are improving clinical workflows. Increasing sports participation, road injuries, obesity-related joint problems, and age-associated degenerative disorders further support imaging utilization. Consequently, orthopedic healthcare remains an important source of demand for diagnostic imaging equipment and services.

Hospital Market

The hospital market represents a major end-use segment for diagnostic imaging because hospitals require imaging across emergency medicine, inpatient care, surgery, oncology, cardiology, neurology, orthopedics, and intensive care. Large hospitals commonly operate multiple imaging modalities, including X-ray, CT, MRI, ultrasound, mammography, and nuclear medicine systems, allowing clinicians to select examinations according to clinical requirements. OECD data show that CT, MRI, and PET availability has increased rapidly across many OECD countries over recent decades, although substantial differences remain between countries and regions. In 2023, combined CT, MRI, and PET examination use exceeded 370 exams per 1,000 population in several OECD countries, including Luxembourg, Korea, Austria, France, and Portugal. Hospitals are also increasingly investing in integrated digital imaging infrastructure, including PACS, radiology information systems, automated workflows, and AI-enabled decision-support technologies. Diagnostic imaging availability is measured not only inside hospitals but also across ambulatory healthcare settings, reflecting the growing role of outpatient imaging centers. As hospitals expand emergency capacity, cancer services, surgical programs, and specialized care, imaging volumes are expected to remain substantial. Digital transformation and demand for faster diagnosis are consequently encouraging continued investment in advanced imaging equipment and supporting technologies.

United States Diagnostic Imaging Market

United States represents a major diagnostic imaging market, supported by extensive hospital infrastructure, advanced technology adoption, and high utilization of CT, MRI, X-ray, ultrasound, and nuclear imaging systems. The Centers for Disease Control and Prevention (CDC) states that medical imaging is routinely used to identify the causes of symptoms, diagnose diseases and injuries, and guide certain treatments. In the U.S., medical diagnostic examinations are also the principal man-made source of ionizing radiation exposure, making radiation optimization and appropriate imaging utilization important components of healthcare delivery. The scale of utilization is substantial: OECD data reported 369 CT, MRI, and PET examinations per 1,000 population in the United States in 2021, among the highest levels recorded across the countries included in its comparison. Demand is further supported by an aging population, chronic disease management, cancer screening, emergency care, and growing outpatient diagnostic services. Healthcare providers are increasingly adopting digital radiography, high-resolution CT and MRI, portable ultrasound, AI-assisted interpretation, and integrated imaging information systems. These developments are supporting faster diagnosis, workflow automation, and broader access to advanced diagnostic capabilities across hospitals and ambulatory facilities.

Germany Diagnostic Imaging Market

Germany has a highly developed diagnostic imaging infrastructure, supported by broad healthcare coverage, extensive hospital capacity, and significant utilization of advanced imaging technologies. MRI and CT examinations are widely incorporated into diagnosis, treatment planning, cancer care, orthopedic assessment, and chronic disease management. According to OECD data, Germany recorded approximately 156 MRI examinations per 1,000 population, based on the latest data presented in Health at a Glance: Europe 2024, demonstrating substantial utilization of MRI services. More broadly, OECD data show that Germany recorded 319 combined CT, MRI, and PET examinations per 1,000 population in 2021, illustrating the country’s extensive use of diagnostic imaging. Germany’s market is also benefiting from increasing healthcare digitization, development of integrated radiology workflows, and adoption of AI-assisted imaging applications. Imaging is particularly important in oncology, where CT, MRI, mammography, and PET-based technologies support diagnosis and follow-up. At the same time, healthcare providers are focusing on efficient utilization because OECD analysis notes that high examination volumes can create concerns regarding unnecessary repeat examinations and healthcare-resource efficiency.

China Diagnostic Imaging Market

China’s diagnostic imaging market is expanding alongside the country’s efforts to strengthen healthcare infrastructure, improve access to diagnostic services, and upgrade medical equipment at county and grassroots healthcare facilities. The National Health Commission has specifically emphasized investment in digital imaging, color Doppler ultrasound, and CT equipment to strengthen primary healthcare capabilities. By the end of 2023, nearly 7,800 community health centers and more than 27,000 township health centers had reached established service-capacity standards, while central government funding has also supported equipment upgrades in county and primary healthcare institutions. China has also established national planning and regulatory frameworks for large medical equipment. During the 14th Five-Year Plan period, the National Health Commission planned the configuration of 3,645 large medical devices nationwide, reflecting continued investment in advanced healthcare infrastructure. CT, MRI, ultrasound, digital radiography, and PET/CT systems are increasingly important for cancer, cardiovascular, neurological, and chronic disease diagnosis. AI-assisted interpretation and digital health platforms are also gaining importance as China seeks to improve diagnostic efficiency and extend specialist capabilities beyond major metropolitan hospitals. Expansion into county-level and rural facilities provides additional opportunities for imaging equipment manufacturers and service providers.

Saudi Arabia Diagnostic Imaging Market

Saudi Arabia’s diagnostic imaging market is developing as part of the country’s broader healthcare transformation under Saudi Vision 2030. The Ministry of Health’s transformation programs emphasize preventive medicine, early detection of noncommunicable diseases, healthcare accessibility, efficiency, and technology-enabled services. Diagnostic imaging is an important component of this transformation because CT, MRI, X-ray, ultrasound, and other modalities support early diagnosis and treatment planning across hospitals and specialized healthcare facilities. A notable example is the Ministry of Health’s radiology services privatization and public-private partnership project in Riyadh, covering radiology departments at seven hospitals. The 10-year project was designed to increase capacity, shorten waiting times, and improve diagnostic services for more than 1.5 million beneficiaries, using modern medical imaging equipment. Digital healthcare is another important development area, with the Ministry identifying advanced diagnostic tools and clinical decision-support systems among the capabilities supported through its e-health transformation initiatives. Continued investment in healthcare infrastructure, preventive screening, digital health, and public-private partnerships is therefore supporting the expansion and modernization of diagnostic imaging services across Saudi Arabia.

Diagnostic Imaging Market Segments

Product

• X-Ray
• CT
• Ultrasound
• Nuclear Imaging
• Others

Application

• Orthopedics
• Cardiovascular
• Neurology
• Pelvic & Abdomen
• Oncology

End User

• Hospital
• Diagnostic Center
• Others

Countries

North America

• United States
• Canada

Europe

• France
• Germany
• Italy
• Spain
• United Kingdom
• Belgium
• Netherlands
• Turkey

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Thailand
• Malaysia
• Indonesia
• New Zealand

Latin America

• Brazil
• Mexico
• Argentina

Middle East & Africa

• South Africa
• Saudi Arabia
• United Arab Emirates

All companies have been covered with 5 Viewpoints

• Overviews
• Key Person
• Recent Developments
• SWOT Analysis
• Revenue Analysis

Key Players Analysis

• FUJIFILM VisualSonics Inc.
• Canon Medical Systems Corporation
• Bruker Corporation
• PerkinElmer Inc.
• Hitachi
• Hologic
• Radnet
• Koninklijke Philips

Report Details: